P709-0271 Screening compound: 1-cyclohexyl-4-{5-methyl-1-[5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carbonyl}piperazine

P709-0271 Screening compound: 1-cyclohexyl-4-{5-methyl-1-[5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carbonyl}piperazine
P709-0271 Screening compound: 1-cyclohexyl-4-{5-methyl-1-[5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carbonyl}piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound P709-0271
1-cyclohexyl-4-{5-methyl-1-[5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carbonyl}piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P709-0271

Molecular Formula

C23H29N7O2 (C23 H29 N7 O2)

Compound Name

1-cyclohexyl-4-{5-methyl-1-[5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carbonyl}piperazine

IUPAC name

1-cyclohexyl-4-{5-methyl-1-[5-(3-methyl-124-oxadiazol-5-yl)pyridin-2-yl]-1H-pyrazole-4-carbonyl}piperazine

SMILES

Cc(n(-c(cc1)ncc1-c1nc(C)no1)nc1)c1C(N(CC1)CCN1C1CCCCC1)=O

InChI

InChI=1S/C23H29N7O2/c1-16-20(23(31)29-12-10-28(11-13-29)19-6-4-3-5-7-19)15-25-30(16)21-9-8-18(14-24-21)22-26-17(2)27-32-22/h8-9,14-15,19H,3-7,10-13H2,1-2H3

InChI Key

BOSYKGLCTGRGNB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27613386

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

435.53

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

2.881

Distribution Coefficient, logD

2.718

Water Solubility, LogSw

-3.03

Polar Surface Area

73.936

Acid Dissociation Constant (pKa)

26.43

Base Dissociation Constant (pKb)

7.06

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

52.20

P709-0271 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with P709-0271 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P709-0271?
Check Price and Availability of P709-0271, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P709-0271 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P709-0271
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P709-0271
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P709-0271 available by request